PSYC Continues to Bolster Leadership Team with Key Sales & Branding Advisory Board Appointments
January 10 2022 - 8:30AM
InvestorsHub NewsWire
PSYC Continues to Bolster Leadership Team with Key
Sales & Branding Advisory Board
Appointments
LAKE OSWEGO, OR
-- January 10, 2022 -- InvestorsHub NewsWire
-- Global Trac Solutions,
Inc. (OTCPink:
PSYC) (“Global” “PSYC” or the “Company”) a media leader for the
emerging sector of medicinal psychedelics, and authorities behind
Psychedelic Spotlight, a top ranking psychedelic news and
information platform, is pleased to announce that as the Company
continues to devote considerable focus towards strengthening its
core leadership team, it is proud to welcome Mitchell J.
Schlesinger and Sarah Abelsohn to the growing PSYC Advisory Board
as key sales and branding expert
additions.
Combined with
the recent additions of Christopher Bitonti and Craig Schlesinger,
the Company believes it is effectively rounding out the PSYC
Advisory Board with passionate professionals who can contribute a
wealth of vital knowledge and expertise to the Company and its
growing Psychedelic Spotlight team across the fields of business
operations, financial management, marketing, sales, and
branding.
With more than
30 years of experience in creative advertising, strategic
marketing, and branding, which includes working for global brands
including Avis Rent-A-Car, Norwegian Cruises, Costa Cruises, and
Marco Polo Cruises, the Company will look to Mr. Schlesinger
for guidance and leadership with strategic brand messaging and
developing and implementing sales and marketing Key Performance
Indicators (“K.P.I.’s”) for its Psychedelic Spotlight media
platform in addition to refining PSYC’s evolving image within the
public market sector.
“I spent my
career building brands with unique product positionings and
innovating them by designing strategic brand implementation
programming,” said Mr. Schlesinger. “The emerging psychedelic
sector is especially unique on several fronts and the cutting edge
of revolutionary medicinal therapies. I look forward to working
with the PSYC team to innovate, monetize, and solidify the
Company’s position as the sector’s dominant news, multimedia, and
business platform for both consumers and business partners. It’s an
exciting time to join PSYC’s dynamic
team.”
Ms. Abelsohn,
meanwhile, will transition into her role as an Advisor for PSYC
after serving as the Director of Psychedelic Spotlight since early
2021. She initially joined the Psychedelic Spotlight team in June
2020 as a sales and marketing consultant and played an integral
role over the past year-and-a-half with developing the dynamic,
industry leading, visual brand aesthetic that is now associated
with Psychedelic Spotlight.
“It gives me great
pride to be joining the PSYC advisory board,” said Ms. Abelsohn. “I
am excited to continue lending my insight and support to the team
and to help impact the growth of our ever-expanding audience for
Psychedelic Spotlight. I believe there is so much in store for this
talented team, I'm humbled at the opportunity to be an Advisor, and
excited for what's to come.”
“Surrounding the
Psychedelic Spotlight team and myself with highly-skilled
individuals who are inspired and passionate about what we are
building here at PSYC provides us with, what I think, is a very
unique competitive advantage in terms of our ability to continue
executing on our fundamental growth and monetization-focused
initiatives throughout 2022 and beyond,” said PSYC CEO, David
Flores. “A critical part of our existing monetization initiatives,
in my opinion, are tied directly to our ability to develop and
deploy effective sales, marketing, and branding initiatives. For
this reason, I am confident that the additions of Mr. Schlesinger
and Ms. Abelsohn to the PSYC Advisory Board will prove extremely
beneficial for PSYC based on the dynamic expertise, knowledge, and
passion they will each be able to contribute at this pivotal time
in our Company’s growth.”
About Global Trac Solutions, Inc.
(OTCPink:
PSYC)
At Global Trac Solutions we are
integrating media, creativity, and technology to develop and deploy
thought-provoking ideas and solutions that are fostering and
transforming the approach to some of society’s most pressing
matters.
PSYC has expressed its intent and
commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA’s more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, we believe investors are speculating that the
psychedelic boom could be bigger than that of cannabis. PSYC is
your source for current investment related news specific to
psychedelic medicines and cutting-edge research improving overall
health, moving this sector into the mainstream.
We are dedicated to a
forward-thinking approach that embraces groundbreaking new
technology and innovations and through the vision of business
development we intend to continue to evolve into these unchartered
territories as the industry leaders of the
future.
Forward-Looking Statements
Disclaimer:
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19 and the success of the current vaccine distribution, the
adverse effect of the Omicron variant, that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are disclosed on the OTC Markets.com website and is not
incorporated by reference into such reports.
Disclaimer: Global Trac
Solutions, Inc. does not in any way encourage or condone the use,
purchase, sale or transfer of any illegal substances, nor do we
encourage or condone partaking in any unlawful activities. We
support a harm reduction approach for the purpose of education and
promoting individual and public safety. If you are choosing to use
psychedelic substances, please do so
responsibly.
Corporate
Contact:
Global Trac Solutions, Inc.
(PSYC)
www.globaltracsolutions.com
(702) 239-1919
psyc@globaltracsolutions.com
OTCPINK: PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Apr 2023 to Apr 2024
